New Delhi, April 7 Biocon Ltd announced on Tuesday the commercial launch of biosimilars Bosaya and Aukelso, indicated for different serious bone conditions, in the US.Bosaya (a biosimilar to Prolia) and Aukelso (a biosimilar to Xgeva) are now available by prescription nationwide through...